Short sellers are already investing in the spacks themselves, and also in the companies that theyre a taking public. Investors buy into em because they believe that whoever's setting up the spack can then go out to find an acquisition target. The upside could be really large. I mean, you know, buy your ten dollars a share, and it could be trading at 20 or 30,. So there's a potential that you could make a lot of money off of it.
Michael Dowling, CEO at Northwell Health, discusses the U.S. government expected to recommend booster shots eight months after people get their second vaccine dose. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Deals Reporter Scott Deveau talk about how the SPAC boom has created fresh targets for short sellers and activists. Ken Leon, Global Director of Industry and Equity Research at CFRA, breaks down Home Depot earnings. And we Drive to the Close with Charlie Massimo, Senior VP at Wealth Enhancement Group.
Hosts: Tim Stenovec and Kriti Gupta. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.